Lion Point Capital, LP - Q2 2023 holdings

$221 Million is the total value of Lion Point Capital, LP's 30 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 48.4% .

 Value Shares↓ Weighting
SMTC NewSEMTECH CORPcall$63,650,0002,500,000
+100.0%
28.76%
SMTC  SEMTECH CORP$62,449,688
+5.5%
2,452,8550.0%28.22%
+15.7%
SellMARINUS PHARMACEUTICALS INC$24,516,678
+35.6%
2,257,521
-13.8%
11.08%
+48.8%
SPY SellSPDR S&P 500 ETF TRput$22,164,000
-63.9%
50,000
-66.7%
10.02%
-60.4%
OAS SellCHORD ENERGY CORPORATION$15,749,581
-44.7%
102,403
-51.6%
7.12%
-39.3%
ARDX SellARDELYX INC$5,175,401
-46.9%
1,526,667
-25.0%
2.34%
-41.8%
BFI  BURGERFI INTERNATIONAL INC$4,311,123
+33.1%
2,745,9380.0%1.95%
+46.0%
MCRB BuySERES THERAPEUTICS INC$3,313,736
-2.1%
691,803
+15.9%
1.50%
+7.5%
SellDURECT CORP$2,978,237
-54.0%
601,664
-57.9%
1.35%
-49.5%
BATL  BATTALION OIL CORP$2,174,888
-13.1%
380,8910.0%0.98%
-4.6%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$1,840,129
+50.6%
130,691
+15.1%
0.83%
+65.4%
BLUE NewBLUEBIRD BIO INC$1,747,832531,256
+100.0%
0.79%
MIST BuyMILESTONE PHARMACEUTICALS IN$1,283,090
-23.4%
450,207
+5.9%
0.58%
-15.9%
ACRS  ACLARIS THERAPEUTICS INC$1,139,642
+28.2%
109,8980.0%0.52%
+40.7%
Sell2SEVENTY BIO INC$1,130,070
-34.8%
111,667
-34.3%
0.51%
-28.4%
CBAY  CYMABAY THERAPEUTICS INC$1,088,704
+25.6%
99,4250.0%0.49%
+37.8%
INSM  INSMED INC$1,062,069
+23.8%
50,3350.0%0.48%
+36.0%
FENC NewFENNEC PHARMACEUTICALS INC$971,300110,000
+100.0%
0.44%
HZNP NewHORIZON THERAPEUTICS PUB L$761,0907,400
+100.0%
0.34%
SNDX NewSYNDAX PHARMACEUTICALS INC$722,08534,500
+100.0%
0.33%
MIRM SellMIRUM PHARMACEUTICALS INC$698,490
-70.0%
27,000
-72.2%
0.32%
-67.0%
NewAADI BIOSCIENCE INC$563,77382,423
+100.0%
0.26%
MRSN NewMERSANA THERAPEUTICS INCcall$480,340146,000
+100.0%
0.22%
ORGN  ORIGIN MATERIALS INC$426,000
-0.2%
100,0000.0%0.19%
+9.1%
HARP BuyHARPOON THERAPEUTICS INC$324,125
+157.3%
456,514
+169.7%
0.15%
+180.8%
BFIIW  BURGERFI INTERNATIONAL INCcall$265,638
+96.2%
2,083,4380.0%0.12%
+114.3%
LUMO BuyLUMOS PHARMA INC$258,558
+52.6%
78,351
+53.0%
0.12%
+67.1%
MSFT  MICROSOFT CORP$34,054
+18.1%
1000.0%0.02%
+25.0%
GOOG  ALPHABET INCcap stk cl c$12,097
+16.3%
1000.0%0.01%
+25.0%
PDCE SellPDC ENERGY INC$7,114
-99.9%
100
-99.9%
0.00%
-99.9%
ExitSTRONGHOLD DIGITAL MINING IN$0-20,000
-100.0%
-0.01%
STSA ExitSATSUMA PHARMACEUTICALS INC$0-319,742
-100.0%
-0.09%
BLU ExitBELLUS HEALTH INC NEW$0-45,000
-100.0%
-0.13%
MRSN ExitMERSANA THERAPEUTICS INC$0-409,120
-100.0%
-0.69%
CTIC ExitCTI BIOPHARMA CORP$0-601,579
-100.0%
-1.04%
MGTA ExitMAGENTA THERAPEUTICS INC$0-4,558,466
-100.0%
-1.49%
ExitCIVITAS RESOURCES INC$0-65,000
-100.0%
-1.83%
ARNC ExitARCONIC CORPORATION$0-712,358
-100.0%
-7.69%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CANADIAN SOLAR INC21Q2 202125.6%
ALCOA CORP21Q1 20228.0%
ISHARES TR19Q3 202339.2%
COMSCORE INC19Q4 20225.8%
HALCON RES CORP15Q3 20233.3%
KINIKSA PHARMACEUTICALS LTD15Q3 20233.1%
LUMOS PHARMA INC15Q3 20232.8%
DURECT CORP14Q3 202210.5%
ARCONIC INC14Q1 20204.4%
MARINUS PHARMACEUTICALS INC13Q3 202311.6%

View Lion Point Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Lion Point Capital, LP Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SIERRA WIRELESS INCJune 07, 20221,810,6714.7%
BATTALION OIL CORPFebruary 14, 2022352,8512.2%
DURECT CORPFebruary 14, 202215,486,0046.8%
LUMOS PHARMA, INC.February 12, 2021407,1924.9%
BurgerFi International, Inc.January 11, 20212,745,93815.7%
Canadian Solar Inc.November 27, 20202,453,7244.1%
NEWLINK GENETICS CORPFebruary 14, 20203,114,7338.3%
CARRIZO OIL & GAS INCOctober 29, 20194,584,4005.0%
LATTICE SEMICONDUCTOR CORPJuly 22, 20196,467,0354.9%
Cimarex Resolute LLCMarch 05, 2019? ?

View Lion Point Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2022-11-14

View Lion Point Capital, LP's complete filings history.

Compare quarters

Export Lion Point Capital, LP's holdings